Clinical Trial Update: Mgt of Chronic Subdural Hematoma Using Dexamethasone [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on dexamethasone for managing chronic subdural hematoma, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: University of Calgary | Conditions: Chronic Subdural Hematoma | Phase 2, Phase 3 | Status: UNKNOWN